Logotype for Linde plc

Linde (LIN) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Linde plc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 sales reached $8.3 billion, up 1% year-over-year, with record adjusted EPS of $3.85 (up 8%) and operating margin of 29.3%, driven by strong pricing and productivity despite flat volumes and a challenging macro environment.

  • Adjusted operating profit rose 6% to $2,422 million, and after-tax return on capital reached 25.7%, up year-over-year.

  • Project backlog execution remains strong, with $7.9 billion in high-quality projects and $700 million in new SOG projects started.

  • Free cash flow for Q2 was $796 million, and $2.1 billion was returned to shareholders via dividends and buybacks.

  • Disciplined pricing and proactive management actions continue to drive earnings growth, with no meaningful economic recovery assumed in guidance.

Financial highlights

  • Q2 operating profit grew 6% to $2.4 billion, with all gas segments expanding margins; EMEA led with a 33.7% margin.

  • Operating cash flow was $1,929 million, down 10% year-over-year due to engineering project prepayment timing.

  • Capex for Q2 totaled $1,133 million, up 32% year-over-year, with project capex up 83%.

  • Free cash flow for Q2 was $796 million.

  • Adjusted EBITDA margin for Q2 was 38.8%.

Outlook and guidance

  • Q3 2024 adjusted EPS guidance is $3.82–$3.92, up 5–9% year-over-year (6–9% ex-FX), assuming no economic improvement.

  • Full-year 2024 adjusted EPS guidance is $15.40–$15.60, up 8–11% year-over-year (9–11% ex-FX), with the bottom end increased by $0.10.

  • Full-year capex expected between $4.0 billion and $4.5 billion.

  • Guidance remains cautious due to ongoing macro uncertainty; proactive measures will be taken if conditions worsen.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more